期刊文献+

影响肾癌患者预后的因素分析 被引量:4

Multivariate analysis of prognostic factors in renal cell carcinoma
下载PDF
导出
摘要 目的:通过多因素分析,探讨影响肾癌预后的因素。方法:对154例肾癌进行回顾性分析,采用Kaplan-Meier法对确定的单因素进行生存率的描述,应用Log-Rank检验对确定的单因素进行筛选,多因素分析采用Cox regression方法对预后因素进行评价。结果:肾癌患者1年、3年、5年累计生存率分别为87%、70%、52%,中位生存期为62.84±3.94月。血尿、贫血、高血压、肿瘤直径、临床分期、围手术期输血史对肾癌患者生存率的影响有显著性差异(P<0.05);肿瘤直径、临床分期、血尿是影响肾癌患者生存率的独立因素(P<0.05)。结论:肿瘤直径、临床分期、血尿是影响肾癌患者预后的重要因素;贫血、高血压、围手术期输血史对肾癌患者预后有一定影响。 Objective:To discuss the effect of prognostic factors on renal cell carcinoma(RCC).Methods:Clinical data of 154 cases of RCC were reviewed retrospectively.Their survival rates were calculated by Kaplan-Meier method and statistical differences were determined by Log-rank test.Significant prognostic factors were evaluated by Cox s multivariate proportional hazard model.Results:1-year,3-years,5-years cumulative survival rates were 87.6%,70.8%,52.8% respectively and the median survival time was(62.84±3.94)month...
出处 《陕西医学杂志》 CAS 北大核心 2008年第12期1599-1601,共3页 Shaanxi Medical Journal
关键词 肾肿瘤/病因学 预后 生存分析 Kidney neoplasms/Etiology Prognosis Survival analysis
  • 相关文献

参考文献11

二级参考文献57

  • 1Storkel S, Thoens W, Jacobi G, et al. Prognostic parameters in renal cell carcinoma-a new approach[J].Eur Urol, 1989,16:416-422.
  • 2Jayson M, Sanders H. Increased incidence of serendipitously discovered renal cell carcinoma [J]. Urology,1998,51:203-205.
  • 3Grabowski M, Huzarski T, Lubinski J, et al. Survival in patients with rare subtypes of renal cell carcinoma.[J]. BJU Int, 2002,89:599-600.
  • 4Kennedy S M, Merino M J, Linehan W M, et al. Collecting duct carcinoma of the kidney[J]. Hum Pathol,1990,21:449-456.
  • 5Leucumberri C D, Podilla N J, Albisu T A, et al. Sarcomatoid renal carcinoma[J]. Arch Esp Urol, 1998,51 :772-775.
  • 6Bensalah K,Tostain J,Vincendeau S,et al.Prognostic significance of thrombocytosis in renal cell carcinoma.J Urol,2004,171:200,abstract 752.
  • 7Karim Bensalah,Emmanuelle Leray,Patricia Fergelot,et al.Guilléand Jean-Jacques Patard,Prognostic Value of Thrombocytosis in Renal Cell Carcinoma.The Journal of Urology,2006,175:859-863.
  • 8Steven C,Campbell.Prognostic Factors for Renal Cell Carcinoma:Integrating Laboratory and Molecular Factors.The Journal of Urology,2006,175:813-814.
  • 9Motzer R J,Bacik J,Schwartz LH,et al.Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma.J Clin Oncol,2004,22:454-63.
  • 10Robert J,Motzer,Jennifer Bacik,et al.Madhu Mazumdar.Prognostic Factors for Survival of Patients with Stage Ⅳ Renal Cell Carcinoma:Memorial Sloan-Kettering Cancer Center Experience.Clinical Cancer Research,2004,10:6302-6303.

共引文献51

同被引文献31

  • 1杨培谦,吕文成,杜林栋,刘丽娜.B超及CT诊断肾脏小肿瘤的临床价值(附48例报告)[J].中华泌尿外科杂志,2004,25(12):822-824. 被引量:11
  • 2吴永安.肾细胞癌分类、分级、分期现状和预后因素[J].医师进修杂志(外科版),2005,28(2):1-4. 被引量:7
  • 3方祖军,燕翔,郑捷,杨醌,陈波,姚孟树,丁强,张元芳.肾癌的病理类型与预后的关系[J].临床泌尿外科杂志,2006,21(4):262-263. 被引量:22
  • 4刘欣,朱剑南,姚宝庚,刘金华.腹腔镜手术治疗泌尿外科疾病15例分析[J].实用诊断与治疗杂志,2006,20(8):609-610. 被引量:2
  • 5Stromberg T,Ekm an S,Girnita L,et al.IGF-1receptor tyrosinekinase inhibition by the cyclolignan PPP induces G2/M-phase ac-cumulationand apoptosis in multiple mveloma ce[J].Blood,2006,107(2):669.
  • 6Raje,N,Anderson,K,C.MultiPle myeloma[J].Current TreatOptions Oneol,2000,1:73.
  • 7SinghalS,MethaJ,DesikanR,et al.Antitumor activity of thalido-midein Refractory multiple myeloma[J].N Engl J Med,1999,341(21):1565.
  • 8Staneovskil,BaltimoreD.NF-kappa B activation:theI kappa B ki-nase revealed[J].Cell,1997,31(91):299.
  • 9Menetrier-Caux,C.et al.Inhibition of the differentiation of den-dritic cells from CD34+progenitors by tumor cells:role of inter-leukin-6and macrophage colony-stimulating factor[J].Blood,1998;92:4778.
  • 10Coussens,L.M.&Werb,Z.Inflammation and cancer[J].Nature,2002,420:860.

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部